Home » ASPREVA ANNOUNCES PRELIMINARY REVENUES FOR FIRST QUARTER 2006 AND REVISES GUIDANCE
ASPREVA ANNOUNCES PRELIMINARY REVENUES FOR FIRST QUARTER 2006 AND REVISES GUIDANCE
Aspreva Pharmaceuticals Corporation , an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines for patients with less common diseases, today announced preliminary revenues of approximately US$62 million for the first quarter of 2006.
MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=PR&Date=20060413&ID=5642170)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May